AMPLEXA GENETICS A/S: Financial statements 2017
CVR: 29428441
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 718,089 and a net result of DKK -2,969,411 compared with DKK -2,695,686 the year before. That is an increase of 63.3% compared with the year before. Equity in the 2017 report amounted to DKK -25,247,503. The company had 6 employees in the financial year.
- Gross Profit
- DKK 718,089
- Profit/Loss
- DKK -2,969,411
- Equity
- DKK -25,247,503
- Total Assets
- DKK 6,331,359
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 718 t. | -3 mio. | -25.2 mio. | 6 |
| 2016 | - | 440 t. | -2.7 mio. | -22.3 mio. | - |
| 2015 | - | 157 t. | -3.4 mio. | -19.6 mio. | - |
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
Keep an eye on AMPLEXA GENETICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
AMPLEXA GENETICS A/S has published its annual report for 2016. Gross profit came to DKK 439,860, and the net result was DKK -2,695,686.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.